[1]
2026. Assessment of prostate malignancy in participants with elevated PSA levels using transrectal ultrasound-guided prostate biopsy. Middle East Journal of Noncommunicable Diseases. 1, 1 (Mar. 2026), 1–7. DOI:https://doi.org/10.61882/MEJNCD.1.1.3.